Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 40.10% is 17% below its 5-year average of 48.53%, near the high end of its 5-year range (-1008.68%–70.16%).
25.33% below its 12-month average of 53.70%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 70.16%.
OPERATING MARGIN
40.10%
OPERATING MARGIN AVG TTM
53.70%
OPERATING MARGIN AVG 3Y
40.65%
OPERATING MARGIN AVG 5Y
48.53%
OPERATING MARGIN AVG 10Y
19.57%
OPERATING MARGIN AVG 15Y
-26.94%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-25.33%
CURRENT VS 3Y AVG
-1.36%
CURRENT VS 5Y AVG
-17.36%
CURRENT VS 10Y AVG
+104.95%
CURRENT VS 15Y AVG
+248.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ironwood Pharmaceuticals, Inc.
Market Cap
$595.78M
Operating Margin
40.10%
TTM Avg
53.70%
3Y Avg
40.65%
5Y Avg
48.53%
Market Cap
$605.22M
Operating Margin
-28.23%
TTM Avg
-27.16%
3Y Avg
-23.27%
5Y Avg
7.30%
Market Cap
$580.22M
Operating Margin
-9.01%
TTM Avg
-13.34%
3Y Avg
-16.36%
5Y Avg
-20.24%
Market Cap
$612.34M
Operating Margin
-12.47%
TTM Avg
-13.07%
3Y Avg
-26.14%
5Y Avg
-20.95%
Market Cap
$563.97M
Operating Margin
-156.36%
TTM Avg
-104.91%
3Y Avg
-81.98%
5Y Avg
-81.61%
Market Cap
$562.50M
Operating Margin
46.95%
TTM Avg
-1.63%
3Y Avg
-11705.79%
5Y Avg
-12269.85%
Market Cap
$569.15M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $595.78M | 40.10% | 53.70% | 40.65% | 48.53% |
| Fulgent Genetics, Inc. (FLGT)vs › | $605.22M | -28.23% | -27.16% | -23.27% | 7.30% |
| OrthoPediatrics Corp. (KIDS)vs › | $580.22M | -9.01% | -13.34% | -16.36% | -20.24% |
| AngioDynamics, Inc. (ANGO)vs › | $612.34M | -12.47% | -13.07% | -26.14% | -20.95% |
| Climb Bio, Inc. (CLYM)vs › | $624.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $563.97M | -156.36% | -104.91% | -81.98% | -81.61% |
| CorMedix Inc. (CRMD)vs › | $562.50M | 46.95% | -1.63% | -11705.79% | -12269.85% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $569.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aura Biosciences, Inc. (AURA)vs › | $635.62M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
99.8%
Operating Margin
40.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 70.16% |
| 2026-03-31 | 68.10% |
| 2025-12-31 | 13.74% |
| 2025-09-30 | 63.64% |
| 2025-06-30 | 52.88% |
| 2025-03-31 | -70.75% |
| 2024-12-31 | 34.78% |
| 2024-09-30 | 27.99% |
| 2024-06-30 | 26.46% |
| 2024-03-31 | 14.72% |
| 2023-12-31 | 31.98% |
| 2023-09-30 | 42.74% |
| 2023-06-30 | -1008.68% |
| 2023-03-31 | 57.75% |
| 2022-12-31 | 63.77% |
| 2022-09-30 | 63.03% |
| 2022-06-30 | 57.24% |
| 2022-03-31 | 59.31% |
| 2021-12-31 | 48.32% |
| 2021-09-30 | 62.82% |
| 2021-06-30 | 62.58% |
| 2021-03-31 | 51.10% |
| 2020-12-31 | 44.04% |
| 2020-09-30 | 44.09% |
| 2020-06-30 | 36.58% |
| 2020-03-31 | 16.55% |
| 2019-12-31 | 39.27% |
| 2019-09-30 | 50.23% |
| 2019-06-30 | 21.11% |
| 2019-03-31 | -79.11% |
| 2018-12-31 | 4.59% |
| 2018-09-30 | -257.44% |
| 2018-06-30 | -49.22% |
| 2018-03-31 | -51.87% |
| 2017-12-31 | 24.16% |
| 2017-09-30 | -22.38% |
| 2017-06-30 | -63.02% |
| 2017-03-31 | -76.11% |
| 2016-12-31 | -7.20% |
| 2016-09-30 | -42.79% |
| 2016-06-30 | -28.18% |
| 2016-03-31 | -2.98% |
| 2015-12-31 | -10.93% |
| 2015-09-30 | -66.17% |
| 2015-06-30 | -151.42% |
| 2015-03-31 | -97.01% |
| 2014-12-31 | -87.00% |
| 2014-09-30 | -217.16% |
| 2014-06-30 | -805.83% |
| 2014-03-31 | -303.92% |
| 2013-12-31 | -929.00% |
| 2013-09-30 | -1146.61% |
| 2013-06-30 | -619.68% |
| 2013-03-31 | -2729.12% |
| 2012-12-31 | -162.71% |
| 2012-09-30 | 49.38% |
| 2012-06-30 | -279.61% |
| 2012-03-31 | -290.95% |
| 2011-12-31 | -21.87% |
| 2011-09-30 | -176.92% |
| 2011-06-30 | -168.28% |
| 2011-03-31 | -181.13% |
| 2010-12-31 | -76.29% |
| 2010-09-30 | -178.44% |
| 2010-06-30 | -158.03% |
| 2010-03-31 | -179.28% |
| 2009-12-31 | -280.51% |
| 2009-09-30 | -54.32% |
| 2009-06-30 | -281.04% |
| 2009-03-31 | -355.00% |
| 2008-12-31 | -337.76% |
